Company intelligence / Profile preview

22C Capital

New York, New York, USA

Ownership: Private
Development stage: Other

Overview

22C Capital is a private investment firm that focuses on technology-enabled businesses, including those in the healthcare data and analytics sector. The firm provides financial capital, operational expertise, and technology resources to its portfolio companies, but does not engage in the development or commercialization of life science products.

Industry: Investors

Partnerships

Advent InternationalSpectrum EquityDefinitive Healthcare (investment)RapidRatings (investment)

Beyond the preview

Go deeper on 22C Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 22C Capital.

Explore the full profile